Why is Predictive Oncology, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-11.04%
EBIT Growth (5y)
3.47%
EBIT to Interest (avg)
-12.76
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.57
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.18%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.07
EV to EBIT
-0.57
EV to EBITDA
-0.60
EV to Capital Employed
-0.08
EV to Sales
5.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
Technical Movement
4What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 32.33 times
PRE-TAX PROFIT(Q)
At USD -3.41 MM has Grown at 50.59%
NET PROFIT(Q)
At USD -3.41 MM has Grown at 50.59%
EPS(Q)
Highest at USD -0.36
-20What is not working for the Company
NET SALES(HY)
At USD 0.04 MM has Grown at -63.07%
NET PROFIT(HY)
At USD -23.5 MM has Grown at -438.96%
ROCE(HY)
Lowest at -1,187.68%
RAW MATERIAL COST(Y)
Grown by 722.28% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.01 times
Here's what is working for Predictive Oncology, Inc.
Pre-Tax Profit
At USD -3.41 MM has Grown at 50.59%
over average net sales of the previous four periods of USD -6.91 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -3.41 MM has Grown at 50.59%
over average net sales of the previous four periods of USD -6.91 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.36
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Inventory Turnover Ratio
Highest at 32.33 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Predictive Oncology, Inc.
Net Sales
At USD 0.04 MM has Grown at -63.07%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Debtors Turnover Ratio
Lowest at 0.01 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 722.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






